This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Praluent
  • /
  • Study of Alirocumab (REGN727/SAR236553) in Patient...
Clinical trial

Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

Read time: 1 mins
Last updated:1st Sep 2012
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest